Colon and Rectal Cancer
Conditions
Brief summary
An experimental study through a randomized clinical trial, without blinding (for participants and the research team), with a control group (not subject to intervention) and an intervention group (subject to two text messages, an automated non-human call or a call made by the administrative assistant, and a phone call made by a physician).
Interventions
OTHERArm1: intervention 1 (SMS+call)
The intervention will consist in two text messages (one and two weeks after received the screening test, respectively), an automated non-human call or a call made by the administrative assistant (three weeks after received the screening test), and a phone call made by a physician (four weeks after received the screening test)
OTHERControl group
The control group will not be subjected to any interventions to increase the adherence to screening.
Sponsors
Instituto de Saude Publica da Universidade do Porto
Local Health Unit Barcelos/Esposende, Public Health Unit
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
49 Years to 75 Years
Healthy volunteers
Yes
Inclusion criteria
Participants must be registered in the ULS of Barcelos/Esposende and meet the following criteria: 1. Age between 50 and 74 years. 2. No symptoms such as weight loss in the last 6 months or gastrointestinal symptoms. 3. No prior diagnosis of CRC. 4. No diagnosis of inflammatory bowel disease (ulcerative colitis or Crohn's disease). 5. No family history of CRC in first- and second-degree relatives diagnosed before age 60. 6. No prior fecal occult blood test (FOBT) in the 11 months before receiving the collection kit or no prior sigmoidoscopy or colonoscopy in the last 24 months.
Exclusion criteria
1. Participants who did not receive the screening kit at home. 2. Participants without a phone number. 3. Participants who do not answer the phone or refuse to participate in the study. 4. Participants unable to consent or perform the screening due to physical, mental, or other conditions that seriously impair comprehension.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Adherence to colon and rectal screening [Time Frame: 6 weeks] | From April 2025 to June 2025 (6 weeks) | Increase in adherence to colon and rectal screening Proportion/cumulative proportion of patients who performed colon and rectal cancer screening among those who were invited to undergo it, after step 1 (SMS1), step 2 (SMS2), step 3 (administrative call) and step 4 (medical doctor call) |
Countries
Portugal
Contacts
Primary ContactMarina Barroso Pinheiro MD, PhD, PhD
Backup ContactDavid Nascimento Moreira MD, Master
Outcome results
None listed